Tech Company Financing Transactions
Spinal Modulation Funding Round
On 6/11/2013, Spinal Modulation raised $45 million in funding from private investors.
Transaction Overview
Company Name
Announced On
6/11/2013
Transaction Type
Venture Equity
Amount
$45,002,251
Round
Undisclosed
Investors
Proceeds Purpose
Proceeds purposes were not disclosed. SEC regulatory filing.
Company Information
Company Status
Private & Independent
Industry
Medical Devices & Instruments
Mailing Address
1135 O'Brien Dr.
Menlo Park, CA 94025
USA
Menlo Park, CA 94025
USA
Phone
Website
Email Address
Overview
The Spinal Modulation Axium Neurostimulator System is a next-generation intraspinal neuromodulation therapy that stimulates the dorsal root ganglion (DRG) to provide a new pain management option. It has shown promising results in managing chronic intractable leg pain, as well as difficult-to-target anatomy such as the back and foot.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
David Wood
Chief Scientific Officer
Jeff Kramer
Chief Technical Officer
Lynn Elliott
VP - Marketing
Dan Brounstein
VP - Operations
Bob Gaffney
VP - Regulatory Affairs
Steven McQuillan
VP - Sales
Martin Chambers
Browse more venture capital transactions:
Prev: 6/10/2013: Scratch Music Group venture capital transaction
Next: 6/11/2013: BrightEdge venture capital transaction
Share this article
Where The Data Comes From
Our team works diligently to record every notable VC transaction. VC investment data records on this site come from news reports and company announcements. The data is sourced from VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs